Quick Answer
Lunai Bioworks Inc. reported R&D Expense of $537.4 thousand for fiscal year 2025.
Lunai Bioworks Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $537.4K | -80.2% |
| 2024 | $2.71M | -35.0% |
| 2023 | $4.17M | -50.3% |
| 2022 | $8.37M | -46.7% |
| 2021 | $15.72M | +234.9% |
| 2020 | $4.69M | +87.9% |
| 2019 | $2.50M | +304.9% |
| 2018 | $617.0K | +883.0% |
| 2017 | $62.8K | -92.2% |
| 2016 | $804.2K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $45.9K | -71.5% | +87.9% |
| September 30, 2025 | $24.4K | -93.7% | -84.8% |
| December 31, 2024 | $161.1K | -74.0% | -58.7% |
| September 30, 2024 | $390.2K | -31.1% | -64.1% |
| March 31, 2024 | $1.09M | +354.6% | +75.2% |
| December 31, 2023 | $620.5K | +90.4% | +9.5% |
| September 30, 2023 | $566.6K | -78.3% | +137.0% |
| March 31, 2023 | $239.1K | -80.3% | -26.6% |
- Lunai Bioworks Inc. showed a decrease of -80.2% in R&D Expense compared to the prior fiscal year.
- Over the 2016–2025 period, Lunai Bioworks Inc.’s r&d expense has declined by 33.2% (from $804.2 thousand to $537.4 thousand).
- The most recent figure is from Lunai Bioworks Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: